Inovio Pharmaceuticals, Inc. (INO)

NasdaqCM • Currently up 0.05 (+2.92%) in today's trading session

Track congressional stock trades in Inovio Pharmaceuticals, Inc. (INO). Analyse trading activity from Nancy Pelosi and other members of Congress using public financial disclosure data.

Inovio Pharmaceuticals, Inc. is currently trading at $1.76, positioned at 56% of its 52-week range ($0.56 – $2.72).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$1.76
24h Change
+0.05 (+2.92%)
52 Week Range
$0.56–$2.72
View on NASDAQ

Inovio Pharmaceuticals, Inc. Price History and Technical Analysis

Congressional Trading Activity for INO

Select to highlight on chart
0 transactions
Compliance: 100%
No data

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$121.6M

Volume

7.78M

Beta

1.71

P/E Ratio

-1.52

Fundamentals

EPS

$-1.16

Div. Yield

-

Open

$1.68

Day Range

$1.62 – $1.77

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Jacqueline E. Shea
IPO Date
1998-12-08

Inovio Pharmaceuticals, Inc. is a biotechnology firm dedicated to the research, development, and market introduction of DNA-based treatments. Its core mission is to prevent and cure illnesses associated with human papillomavirus (HPV), various types...

Earnings

Next Report

Q4 2026

11 Mar

EPS Est.

$-0.15

Rev. Est.

$50K

Days Until

109

Recent Quarters

Q3 202610 Nov
EPS$-0.50
Miss 141.9%
Q2 202612 Aug
EPS$-0.07
Beat 67.7%
Q1 202613 May
EPS$-0.28
Beat 20.0%
Q4 202512 Mar
EPS$0.06
Beat 116.2%
Q3 202510 Nov
EPS$-0.87
Miss 106.3%
Q2 202512 Aug
EPS$-0.61
Beat 3.2%
Q1 202513 May
EPS$-0.51
Beat 31.1%
Q4 202418 Mar
EPS$-0.69
Beat 20.7%
Q3 202414 Nov
EPS$-0.89
Beat 25.8%
Q2 20248 Aug
EPS$-1.19
Miss 3.5%
Q1 202413 May
EPS$-1.31
Miss 21.3%
Q4 20236 Mar
EPS$-1.12
Beat 11.8%
Q3 20239 Nov
EPS$-1.08
Beat 30.8%
Q2 20239 Aug
EPS$-1.56
Beat 7.1%
Q1 202310 May
EPS$-1.92
Miss 14.3%
Q4 20221 Mar
EPS$-2.52
Miss 31.3%
Q3 20228 Nov
EPS$-1.80
Beat 48.3%
Q2 20229 Aug
EPS$-5.52
Miss 53.3%
Q1 202210 May
EPS$-4.32
Miss 28.6%
Q4 20211 Mar
EPS$-6.00
Miss 51.5%
Q3 20219 Nov
EPS$-3.48
Beat 12.1%
Q2 20219 Aug
EPS$-4.68
Miss 56.0%
Q1 202110 May
EPS$-3.24
Miss 50.0%
Q4 20201 Mar
EPS$-1.68
Beat 36.4%
Q3 20209 Nov
EPS$-2.64
Miss 22.2%
Q2 202010 Aug
EPS$-2.76
Miss 27.8%
Q1 202011 May
EPS$-3.12
Miss 8.3%
Q4 201912 Mar
EPS$-3.84
Miss 39.1%
Q3 201912 Nov
EPS$-3.24
Beat 0.0%
Q2 20198 Aug
EPS$-3.60
Miss 7.1%
Q1 20199 May
EPS$-3.60
Miss 3.5%
Q4 201812 Mar
EPS$-4.08
Miss 13.3%
Q3 20188 Nov
EPS$-3.24
Beat 15.6%
Q2 20187 Aug
EPS$-0.96
Beat 77.1%
Q1 20189 May
EPS$-4.32
Miss 33.3%
Q4 201714 Mar
EPS$-2.88
Beat 25.0%
Q3 20178 Nov
EPS$-4.80
Miss 73.9%
Q2 20178 Aug
EPS$-1.56
Beat 18.8%
Q1 201710 May
EPS$-3.72
Beat 11.4%
Q4 201615 Mar
EPS$-4.32
Miss 24.1%
Q3 20169 Nov
EPS$-3.36
Miss 7.7%
Q2 20168 Aug
EPS$-3.12
Beat 0.0%
Q1 20169 May
EPS$-1.32
Beat 52.2%
Q4 201514 Mar
EPS$-3.00
Miss 31.6%
Q3 20159 Nov
EPS$0.84
Beat 800.0%
Q2 201510 Aug
EPS$-1.20
Miss 100.0%
Q1 201511 May
EPS$-2.16
Miss 400.0%
Q4 201416 Mar
EPS$-1.44
Beat 20.0%
Q3 201410 Nov
EPS$-1.44
Miss 9.1%
Q2 201411 Aug
EPS$-2.28
Miss 11.8%
Q1 201412 May
EPS$-2.40
Miss 25.0%
Q4 201317 Mar
EPS$-0.28
Miss 100.0%
Q3 201312 Nov
EPS$-1.44
Beat 0.0%
Q2 20139 Aug
EPS$-2.40
Miss 150.0%
Q1 201310 May
EPS$-1.92
Miss 1029.4%
Q4 201218 Mar
EPS$-0.96
Miss 433.3%
Q3 20127 Nov
EPS$-0.20
Miss 42.9%
Q2 20129 Aug
EPS$-0.12
Beat 29.4%
Q1 20129 May
EPS$-0.24
Miss 33.3%
Q4 201115 Mar
EPS$-0.16
Beat 20.0%
Q3 20117 Nov
EPS$-0.16
Miss 23.1%
Q2 20118 Aug
EPS$-0.08
Beat 57.9%
Q1 201111 May
EPS$-0.08
Beat 46.7%
Q4 201017 Mar
EPS$-0.28
Miss 86.7%
Q3 201015 Nov
EPS$-0.04
Beat 63.6%
Q2 201016 Aug
EPS$-0.28
Miss 250.0%
Q1 201017 May
EPS$-0.08
Beat 55.6%
Q4 200929 Mar
EPS$-0.28
Miss 75.0%
Q3 200916 Nov
EPS$-0.12
Beat 40.0%
Q2 200919 Aug
EPS$-0.76
Miss 216.7%
Q1 200914 May
EPS$-0.31
Q4 200831 Mar
EPS$-0.32
Miss 14.3%
Q3 20087 Nov
EPS$-0.20
Beat 47.4%
Q2 20087 Aug
EPS$-0.36
Miss 28.6%
Q1 20089 May
EPS$-0.28
Beat 36.4%
Q4 200717 Mar
EPS$-0.08
Beat 83.0%
Q3 20078 Nov
EPS$-0.44
Miss 12.8%
Q2 20078 Aug
EPS$-0.44
Miss 10.0%
Q1 20079 May
EPS$-0.44
Miss 18.9%
Q4 200616 Mar
EPS$-0.56
Miss 30.2%
Q3 20068 Nov
EPS$-0.44
Miss 10.0%
Q2 20068 Aug
EPS$-0.40
Miss 11.1%
Q1 20069 May
EPS$-0.36
Beat 18.2%
Q4 200516 Mar
EPS$-2.40
Miss 275.0%
Q3 20059 Nov
EPS$-0.64
Beat 25.6%
Q2 20059 Aug
EPS$-0.44
Beat 52.2%
Q1 200510 May
EPS$-0.88
Beat 0.0%
Q4 200415 Mar
EPS$-0.84
Miss 2.4%
Q3 200415 Nov
EPS$-0.80
Miss 53.9%
Q3 200412 Nov
EPS$-0.77
Q1 200415 May
EPS$-0.40
Beat 37.5%
Q4 200330 Mar
EPS$-0.48
Beat 0.0%
Q2 200312 Aug
EPS$-0.44
Q1 200320 May
EPS$0.06
Q4 200231 Mar
EPS$-0.50
Q3 200213 Nov
EPS$-0.55
Q2 200214 Aug
EPS$-0.62
Q1 200215 May
EPS$-0.68
Q1 20021 Apr
EPS$-3.42
Q3 200116 Nov
EPS$-0.81
Q2 20019 Aug
EPS$-1.27
Q1 200118 May
EPS$-1.57
Q4 200012 Feb
EPS$-1.27
Q3 20009 Nov
EPS$-1.12
Q2 200014 Aug
EPS$-1.29
Q1 200028 Jun
EPS$-1.63
Q4 199910 Feb
EPS$-1.44
Q3 199912 Nov
EPS$-1.60
Q2 199913 Aug
EPS$-2.24
Q1 199929 Jun
EPS$-2.08
Q3 199831 Dec
EPS$0.80

Dividends

Dividend History

28 Sept 2017
Amount $0.0690
29 Aug 2017
Amount $0.0690
27 Jul 2017
Amount $0.0690
28 Jun 2017
Amount $0.0690

Stock Splits

Split History

25 Jan 2024Reverse Split
Ratio1:12
6 Jun 2014Reverse Split
Ratio1:4
13 Sept 2004Reverse Split
Ratio1:4

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.